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Abstract
Hospitals across America have intensive care units dedicated to neonates who are born
with a wide variety of issues, with the hope that specialized care will promote healthy growth so
the newborn can return home with its family. Unfortunately, the majority of the country is seeing
an increase in neonates being born with drugs in their system from their mother’s dependency
during pregnancy. Delivering mothers who were addicted to opioids quadrupled between
1999-2004, which resulted in an increase of infants born with Neonatal Abstinence Syndrome
from 1.2 per 1000 births in the year 2000 to 5.63 per 1000 births in 2012 (Kondili & Duryea,
2019). These babies are born with the substances circulating through their own body as a result
of the drugs passing from the mother’s system across the placenta into the baby. Shortly after
birth these infants begin experiencing withdrawal from the substance since it is no longer being
provided to them through the mother. The withdrawal process is similar to adults, although often
negatively impacts the baby for both the short and long term future. The traditional method for
treating these infants is to administer opioids to stop the withdrawal symptoms then slowly wean
the baby from medication. Since the incidence of infant drug withdrawal is increasing, some
Neonatal Intensive Care Units (NICU) have implemented programs and protocols for the
withdrawal that promote healing and comfort without using medications alone. This has not yet
become a widely accepted practice due to lack of funding or space (Mangat, Schmolzer & Kraft,
2019). This review of literature will investigate why these specialized programs are needed and
in what ways the program benefits these babies.
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Introduction
During 2017 roughly 2.6 million people were addicted to and/or misused opioids in
America (Kondili & Duryea, 2019). It is clear that opioid misuse has severely impacted this
country, which has resulted in a direct effect on medical centers. One medical specialty that has
been altered by the crisis is women’s and children’s units. Between 2009 and 2017 the amount of
women using heroin and prescription pain medication doubled (Kondili & Duryea, 2019).
Specifically, the statistics show that the amount of women admitted to labor and delivery units
who had an opioid problem quadrupled between the years 1999 and 2014 (Kondili & Duryea,
2019). Therefore, the country’s medical systems have made big changes in order to treat these
opioid dependent babies.
Due to the rise of pregnant women using drugs there is also a growing rate of newborns
who are born also addicted to the substance (Kondili & Duryea, 2019). Just like all nutrients, the
drugs are passed from the mother to fetus via placental perfusion of blood. Each drug has
varying transportation pathways, peak times, and addiction rates. But no matter the substance
(even alcohol), it will reach fetal circulation. The drug affects the fetus in similar ways as it does
to an adult; stimulants will result in an increased heart rate, rapid movement, and central nervous
system stimulation, while a depressant will slow heart rate, decrease movement, and suppress the
central nervous system (MacMullen, Dulski & Blobaum, 2014). In utero the fetus will be
affected by the drug, but it is not until post-delivery that the true impacts of his/her mother’s
addiction will truly begin to manifest itself. Once the umbilical cord is cut, the newborn is no
longer receiving any blood or nutrition from the mother; this includes a halt of the drug
circulating. Therefore, the newborn has now entered the withdrawal period, better known as
Neonatal Abstinence Syndrome (NAS). Withdrawal post-delivery can occur from any form of an
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addictive substance – opioids, prescription medications, alcohol, and marijuana. NAS is seen is
55-94% of newborns who had a drug-dependent mother (Ghazanfarpour et al., 2019). The
symptoms of withdrawal do not occur immediately after birth, but rather present themselves once
the substance level reaches below the threshold that the infant was expecting in utero. The onset
of symptoms ranges from a few hours post-delivery up to eight days (Ghazanfarpour et al.,
2019). “The effect of drugs on body system is also influenced by the type of drug, the
combination of drugs, the amount and frequency of use, the trimester in which the drug was
used, the timing of withdrawal, and the genetic susceptibility of the fetus/neonate” (MacMullen,
Dulski & Blobaum, 2014). There is evidence to believe that many NAS patients were poly-drug
exposed (mother used more than one substance), which also results in varying onsets and
symptoms. (Konduli & Duryea, 2019).
The overall statistics show that the average length of stay in a neonatal intensive care unit
for NAS patients is 16 days (Wachman, Schiff & Silverstein, 2018). NAS patients are in need of
these lengthy stays due to the severe symptoms that accompany this syndrome. The hallmark
signs are high pitched cry, diarrhea, excessive sucking, insomnia, irritability, sneezing,
regurgitation, and mottling of the skin (Neonatal Abstinence Syndrome, 2014). The intensity of
the symptoms varies with the substance used during pregnancy, but overall these are the classic
signs of NAS. The diagnosis of NAS is made by a neonatal provider via prior knowledge of
maternal ingestion, blood screening, or urine analysis (Neonatal Abstinence Syndrome, 2014).
Once a diagnosis is made a full evaluation and work up must be done on the infant and he/she
will likely be transferred from the postpartum unit to the NICU for closer monitoring. As
previously discussed, the onset of symptoms varies so there must be frequent monitoring of the
newborn to assess when the withdrawal officially begins which will then dictate the treatment
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options. The most popular assessment tool for medical staff to assess NAS patients is the
Finnegan scoring system; 65-95% of NICUs across America using this system to score their
infant patients (Ryan et al., 2017). This scoring assessment form monitors different symptoms
expected in newborn with NAS including: gastrointestinal upset (loose stool, vomiting, poor
feeding), respiratory indicators (tachypnea, sneezing, congestion), tremors (either disturbed or
undisturbed), amount of time sleeping, presence of moro reflex, muscle tone, rectal temperature,
and irritability level (Mangat, Schmolzer & Kraft, 2019). If the newborn presents with the sign or
symptom, then points are added to their overall score. If the score is greater than eight the baby is
considered in active withdrawal and will be diagnosed with Neonatal Abstinence Syndrome
(Ryan et al., 2017). The overall score can drastically change within a shift, so the nurses are
scheduled to complete this assessment every two hours on average (Neonatal Abstinence
Syndrome, 2014). Due to the extended time period in between assessments the nurse includes all
observations seen between the scorings, not just score based on symptoms seen at that very
moment because it could alter the system. The Finnegan system has proven to be very effective
in allowing providers and nurses to make a successful plan of care in managing the newborns
symptoms via treatment options.
The traditional mode of treatment for NAS patients is to administer opioids once the
patient begins displaying symptoms. In order to prevent such a drastic withdrawal for the patient,
giving them an opioid such as morphine will soothe their symptoms. The overall goal of this
therapy is to slowly wean the medication dosages over time so the withdrawal occurs slowly
where the symptoms can be managed. “Goals of pharmacological therapy are to relieve infant
discomfort, allow proper nutrition and development, and to foster parental bonding.” (Mangat,
Schmolzer & Kraft, 2019). Pharmacological therapy is usually given when an infant receives a
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Finnegan score of greater than 8 on two consecutive assessments (Kondili & Duryea, 2019). The
two medications that are most often prescribed for NAS are morphine and methadone (Mangat,
Schmolzer & Kraft, 2019). Morphine is an opioid agonist, which means that it inhibits the neural
cell receptor sites to prevent signals of pain from traveling to the brain. This medication is the
most widely used opioid to treat NAS with 80% of NICUs in America prescribing it as the first
line therapy option (Mangat, Schmolzer & Kraft, 2019). The dosing is up to the provider’s
discretion but is usually started on a higher dose and weaned off after the Finnegan scoring drops
below eight consistently for forty-eight hours (Neonatal Abstinence Syndrome, 2014). Another
medication given to treat NAS is methadone, which is another opioid agonist and works in
similar ways to morphine. Methadone is used far less with only 20% of health systems
prescribing this therapy option (Mangat, Schmolzer & Kraft, 2019).
Regardless of the medication prescription, the chain of action is similar once the first
dose is given. During the initiation phase a higher dose of the opioid is given, which will
hopefully decrease the scoring and allow the infant relief of symptoms. The assessments still
continue to monitor any status changes. Two roads are possible now that the first dose is given:
either the baby can respond negatively and have a Finnegan score of greater than or equal to
eight which will prompt the provider to increase the dose in order to reach therapeutic levels, or
the baby can respond positively and drop the scoring below eight which will result in a stable
dose for forty-eight hours (Mangat, Schmolzer & Kraft, 2019). The weaning phase occurs after
the baby’s scores have stabilized for forty-eight hours (Mangat, Schmolzer & Kraft, 2019). In
this phase the dosages will be decreased over time to the point of stopping the medication
completely. Many infants will enter the weaning phase only to have to be increased again, just
because their bodies were not able to tolerate the decreased dose (Neonatal Abstinence
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Syndrome, 2014). Each baby is different, so the phases will look different for each one; it may
take a week or a month, but this is the pharmacological treatment platform.
Pharmacological treatment is first line management once Finnegan scoring reaches
greater than an eight because it is the less expensive option, requires less medical staff
interaction and time, and has rapid results with the proper dosing (Neonatal Abstinence
Syndrome, 2014). As stated before the average NICU stay for an infant experiencing NAS is 16
days (Wachman, Schiff & Silverstein, 2018). The days spent in an ICU are very expensive for
the patient and the hospital system, so any method to decrease the length of stay is positive. The
average cost for a NAS infant to stay in a NICU is $2,700 per day (MacMullen, Dulski &
Blobaum, 2014). These costs come from medical staff, procedures, medications, room and board,
charting systems, and feedings. Again, this high cost motivates medical staff and parents to
decrease the length of stay. While pharmacological treatment options are needed and effective,
there are other forms of treatment that have been proven to decrease length of stay for NAS
patients. These therapies exclude medication administration but focus more on the newborn’s
environment. The purpose of this literature review is to examine the ways in which the
previously stated non-pharmacological treatment options benefit infants experiencing
withdrawal. The thesis will argue that these therapy options have a large enough benefit for
Neonatal Intensive Care Units to implement the practices in their protocols for patients
diagnosed with NAS.
Methodology
This thesis will be a literature review of previous research projects and articles
pertaining to this topic of non-pharmacological therapies for Neonatal Abstinence Syndrome
(NAS) patients. This thesis investigates the major treatment options that are being conducted in
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hospitals in the United States. The paper explores each option’s success rate in relation to length
of stay, syndrome symptoms, and medication dosages. Data bases searched were CINHAL,
Medline, and Google Scholar. The paper uses a few news articles concerning the implementation
of this type of therapy in hospitals local to Lynchburg. Some search terms used were: “NAS
treatment”, “Non-pharmacological therapy for NAS”, “Pods for NAS”, “Medications for NAS”
and “Rooming In for NAS”.

Environmental Modifications
The simplest non-pharmacological treatment options that require less money, time, and
energy include alterations in the newborn’s environment while staying in the NICU. Due to these
patients being hypersensitive to noise, light, and movement simple changes in their atmosphere
can have a large impact on length of stay, medication administration, and overall wellbeing
(MacMullen, Dulski & Blobaum, 2014). Some of these environmental changes are employed
with the typical baby in the NICU, but it is even more pertinent for NAS patients. Swaddling the
baby, which involves wrapping a blanket tightly around the child, is a commonly used practice in
most newborns to promote feelings of security, increased sleeping time, prevent waking, and
assist in overall betterment of the infant (Ryan et al., 2017). There are countless studies proving
the benefits of swaddling in the newborn, but specific research has yet to be conducted relating
swaddling to the NAS patient specifically. The current literature shows that when done properly,
swaddling reduces crying, lengthens sleep, and assists with comfort in the average newborn
(Thompson, 2003). Yet ties can be drawn from the benefits for the average newborn to NAS.
Since NAS patients have an increased sensitivity to movement and insomnia, it is clear that if
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swaddling decreases these symptoms in the healthy newborn it will especially help these
patients. It is a widely accepted practice in NICUs that is effective for infants regardless of
diagnosis (Mangat, Schmolzer & Kraft, 2019).
Another simple, yet effective measure is to place these infants in the prone position (on
their stomachs). While positioning newborns in this fashion is warned against at home due to the
risk of Sudden Infant Death Syndrome, it has been proven effective for NAS when monitoring of
the heart rate is constant and nursing checks are frequent (Mangat, Schmolzer & Kraft, 2019).
Positioning the infant in this manner has proven to cause greater sleeping times, decreased
arousal, stable respiratory patterns, and effective heart rhythms (Mangat, Schmolzer & Kraft,
2019). A study compared the Finnegan scores for infants lying in the prone position versus
supine and found that the prone positioned patients had lower scores overall than the supine by
two points (Mangat, Schmolzer & Kraft, 2019). It is thought that proning infants has a positive
effect on the cardiac and respiratory systems, causing relaxation (Mangat, Schmolzer & Kraft,
2019). This is a very simple task for nurses to put into practice with their NAS patients because it
requires no extra skills, finances, or much more time but produces positive outcomes.
In traditional NICUs each patient has a bassinet crib or incubator to lie in that provides
safety, comfort, and warmth. These beds are ideal for the average baby, but studies have proven
that waterbeds actually improve NAS symptoms. While these beds will cost the medical system
more money than the typical bed, the benefits for NAS make the cost worthwhile. A study of
NAS patients placed on waterbeds showed that these patients had a decrease in medication
dosage by 2milligrams per kilogram, decreased Finnegan scores, and began gaining weight
earlier than patients in typical cribs (Ryan et al., 2017). The outstanding benefits of these

8

waterbeds ought to outweigh the costs for NICUs as a means for decreasing the symptoms of
NAS.
Changes to the environment for NAS patients has shown to make a difference in their
overall wellbeing and symptoms. The average NICU is a place with bright overhead lighting and
constant noise of machines, crying, and voices – not an ideal environment for hypersensitive
newborns. Any way to decrease the stimulation for an infant experiencing NAS will only bring
about positive improvements for their scores, length of stay, and medication administration. One
way to combat the environmental commotion is to create low-stimuli pods. The pods are separate
areas for the NAS infants to reside in while completing their treatment at the hospital. It has
lower light, decreased amount of noise, and areas for parents to sit alongside their newborn. The
pods create an ideal environment for the withdrawal period by largely decreasing stimuli. A
hospital in Lynchburg, Virginia recently constructed pods for their NAS population. Centra
Health, also seeing a growing rate of NAS patient’s coming into their hospital, decided to combat
this issue by creating the pods to assist their patients. The Women’s and Children’s manager,
Shannon Miles, stated, “Part of the initiative is to have these neonatal pods that are available so
moms can be at the bedside with their infants, they can hold their infants, do skin to skin,
breastfeed if they want to, pump if they need to, and have privacy. They will have the lights
down for dimness, have quiet time – all these things that a baby who might experience neonatal
absence will need.” (Centrahealth.com, 2018). Hospitals, like Centra Health, are implementing
these pods because of research that proves the benefits. One study in particular showed that NAS
infants who were placed in low stimuli environments had a 50% decrease in their average length
of stay (Grossman et al, 2017). While constructing these pods is an expensive undertaking, it
truly does help the babies combat this syndrome in an ideal environment. But unfortunately,
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hospitals in America do not have plentiful financial reserves that can be used to construct pods.
This is not to say that the low stimuli environment idea has to be completely abandoned. There
are still ways that nurses can help create this atmosphere within the NICU by placing their bed in
a corner of the unit, away from doors and the nurses station to decrease sound. They can also be
sure that ceiling lights are not directly over the crib and in the baby’s eyes. Another simple way
to decrease stimulation is to cluster nursing care as much as possible. This means that the nurse
can construct her tasks during the day to take place at once instead of waking the baby more than
it needs to be. Nurses can cluster the baby’s morning assessment, feeding, and medication
administration together so that sleep is promoted. These are simple ways that the environment
can be set up to encourage rest and comfort for NAS patients who are hypersensitive to their
surroundings.
Feeding and Nutrition
A topic of investigation and research surrounding NAS patients is their feeding schedule,
method, and nutrition. There are differing opinions concerning the safety of breastfeeding when a
mother is on drugs because of the fear that substance could yet again travel into the newborn’s
system via breast milk. Although many providers are still very cautious about NAS patients
breastfeeding, evidence has shown that breastfeeding is a safe and therapeutic way of nutrition.
Research has been done on mothers taking opioid substitution therapies to treat their addiction,
including methadone and buprenorphine (Mangat, Schmolzer & Kraft, 2019). Research does not
support the implementation of breastfeeding for mothers still using illicit drugs because those
substances will have harmful effects for the baby (Ryan et al., 2017). Two studies looked at the
concentrations of methadone in the breastmilk of mothers taking 40-200 mg per day; research
showed that only 2% of the drug was being excreted in the milk to be available for the newborn,
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which would decrease even more due to the low bioavailability of oral intake (Ryan et al., 2017).
There have been no detrimental effects to the newborns after receiving breastmilk from mothers
on opioid-substitution therapies (Mangat, Schmolzer & Kraft, 2019). In the maternal and fetal
medicine world breastfeeding is the golden standard for promoting newborn growth and
development regardless of newborn status. Not only does breastfeeding have numerous benefits
for the healthy newborn, it also assists NAS patients as well. Evidence has shown that NAS
babies who are breastfed have consistently lower symptoms than formula-fed individuals. “A
retrospective chart review of 190 drug-dependent mother-infant-dyads showed reduced NAS
severity within the first 9 days and delayed onset, 25% reduction in need for pharmacological
treatment, and up to 20-day decrease in lengths of pharmacological treatment, regardless of
gestation and type of drug exposure when compared to formula fed.” (Mangat, Schmolzer &
Kraft, 2019). Another study showed a decrease of 7 days in the overall length of stay for
breastfed NAS patients over formula fed (Mangat, Schmolzer & Kraft, 2019). The benefits of
breastfeeding are clear, but it is difficult to put into practice because the babies are often
separated from the mother during hospital stay, and the willingness to breastfeed of this maternal
population is low.
A statistical study shows that only 24% of mothers who gave birth to NAS babies will
breastfeed (MacMullen, Dulski & Blobaum, 2014). The small percentage that does breastfeed
drops by 60% after 6 days post-delivery (MacMullen, Dulski & Blobaum, 2014). The causes for
this low percentage is largely caused by a lack of education prenatally and during the postpartum
period (MacMullen, Dulski & Blobaum, 2014). Many of these mothers do not seek care
prenatally due to lack of finances or other resources. They may also be afraid of the outcomes
due to their drug dependence. Once the baby is born, the focus immediately goes to decreasing
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NAS symptoms via medications and much of the other non-pharmacological treatment options
are pushed to the side or not fully explained to the mother (Ryan et al., 2017). Some hospitals
are starting initiatives to increase the rates of breastfeeding by following steps outlined by Baby
friendly Inc. and decreasing barriers to breastfeeding noticed within their facility (Ryan et al.,
2017). Another major issue is the physical separation during hospital stay because the baby is
admitted to NICU and the mother to postpartum, so in order for her to breastfeed she would need
to come to the ICU every feeding, which is a large barrier for many new moms. A possible
solution for this issue is to allow the mother to pump as needed in order to consistently feed the
infant breastmilk rather than switching between formula. The skin to skin contact would not be
occurring with pumping, but the nutritional benefits of breastmilk would still be present.
Since there is such a low rate of breastfeeding in this population, formula feeding
techniques and methods must be considered. Some of the symptoms of NAS affect the
gastrointestinal tract which results in diarrhea, regurgitation, excessive sucking, and poor feeding
in general (MacMullen, Dulski & Blobaum, 2014). These issues easily lead to inadequate
nutrition which results in low weight and delayed development for the newborn. Practices must
be put in place to decrease and prevent this from happening so the infant can be discharged
earlier and be on track for target developmental milestones/growth. The formula itself is often
prescribed by the neonatal provider to best suit the baby’s needs. NAS patients need to be placed
on formulas with high calories and/or sensitive ingredients to prevent regurgitation and reflux
(MacMullen, Dulski & Blobaum, 2014). Since they are prone to GI upset due to their syndrome,
the formula often needs to be changed and revised until it seems to work well for the patient. The
schedule that seems to work best for these infants is small meals that occur on a frequent basis to
ensure that the largest amount can be fully digested before another feed (MacMullen, Dulski &
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Blobaum, 2014). Sometimes gavage feeding is needed for these infants because their sucking
reflex is overstimulated, and they just cannot ingest the milk. Gavage feeding is a method to
offer nutrition to infants who cannot swallow and/or suck properly. A nasogastric tube is placed,
which allows formula or breastmilk to bypass the mouth and esophagus to directly enter the
stomach for digestion. Often times as the syndrome’s symptoms decrease, the baby will begin
sucking normally, but while withdrawal is occurring, gavage feeding may be necessary
(MacMullen, Dulski & Blobaum, 2014). Another method for assisting theses infants with
feeding is to attach a slow flow nipple to the bottle. This allows the baby to take in a more
moderate and appropriate amount of formula even though they are having an excessive suck.
Also making sure to position the baby in an upright position after feeding to promote digestion
and prevent regurgitation can be helpful in promoting proper nutrition. As previously stated,
breastfeeding is by far the optimal method of nutrition for this population, but since the rates of
this occurring are low, other feeding methods are available to help prevent and/or decrease
gastrointestinal upset in these patients.
Another issue that arises with NAS feedings is the very high rates of disruptive infant
behaviors that result in inadequate intake. One study examined the behaviors of infants during
feedings and found that 51% of the feeding time the infants were expressing fussiness and crying
(Maguire et al, 2015). Other characteristics that are common for NAS patients to express during
feedings are sleeping and sedation where they are not interested in eating (Maguire et al, 2015).
This can make feedings very difficult to attempt and especially be successful with. NICU staff
must teach mothers and caregivers about the expected characteristics of their baby during
feedings so they do not become overwhelmed or hopeless. The feeding time is a very important
educational opportunity for nurses to teach about symptoms and why the baby is acting fussy.
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NAS infant character is another limitation in breastfeeding, but with proper education and
preparedness it is a hurdle that can be crossed.
Therapeutic Therapies
A non-pharmacological therapy option that has recently gained traction to warrant
research is providing acupuncture for NAS patients to decrease their symptoms. While the
current research is limited, the findings are showing positive outcomes. There are two main types
of acupuncture studied with the NAS population. The first is traditional acupuncture that
involves inserting a small needle into the top layers of the skin to stimulate different pressure
points of the body (Boucher, 2017). The National Acupuncture Detoxification
Association/NADA recommends inserting the needles at three points along the ear in newborns
to produce the most successful effect (Boucher, 2017). Another type is laser acupuncture which
is a non-invasive form that imitates acupuncture points by using a laser beam on low power
(Mangat, Schmolzer & Kraft, 2019). With either form it is theorized that this therapeutic
procedure works by releasing dopamine into the blood stream. Acupuncture helps patients in
drug withdrawal because, during a high from opioids, large amounts of dopamine are released
just like is occurring during the acupuncture procedure (Mangat, Schmolzer & Kraft, 2019). A
research study compared 14 infants who were receiving morphine administration and
acupuncture therapy versus 14 infants who were being administered the medication solely. The
findings concluded that the infants getting acupuncture had a large decrease in the average time
they continued to receive the medication over the patients only getting morphine by 11 days
(Ryan et al., 2017). Other trials have been conducted but have led to inconclusive answers, which
leads medical providers to accept this therapy as an option but not encourage every NAS patient
to receive it until further investigation is completed (Boucher, 2019).
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Irritability is a classic symptom of NAS that produces a high-pitched cry which is almost
impossible to console without the assistance of a soothing technique. Due to the hypersensitive
state these babies are in, anything can send them into a complete wreck which also will
negatively affect their vital signs, leading to hypertension, inadequate oxygen exchange, and
tachycardia (Neonatal Abstinence Syndrome, 2014). All too often NICU nurses are given a high
patient load and cannot care for two or more NAS infants at once. They truly need one-on-one
attention to console them and decrease their stimulation; unfortunately, the shortage of nurses in
America right now makes that unable to be a reality. So nurses look for anyway to console their
patients, even if it is for long enough to complete charting or talk with the provider. An option
that is used in the newborn population, but often for small procedures, is oral sucrose. Often
nurses or providers will drop this sucrose/sugar water on the infant’s tongue or dip their pacifier
in the liquid to produce a calming disposition. Sucrose given orally is a mild analgesic that is
given to reduce pain (Kedrick, 2018). It has a calming effect for newborns that only last 5-8
minutes, so it is a good choice to reduce pain for the short term (Kedrick, 2018). Some traditional
uses for sucrose administration are: heel sticks, IV insertion, lumbar punctures, dressing changes,
injections, circumcision, enemas, and nasogastric tube insertions (Kedrick, 2018). NICU nurses
caught onto the idea that sucrose calms infants during these procedures, therefore it ought to
relieve distress in NAS infants. As previously stated, its effect wears off quickly so back up plans
must be in place to console the infant, but for a short term fix sucrose can console an irritable
patient. One issue that can arise from giving sucrose is raising the infant’s blood glucose level to
unsafe ranges. Because of this possibility there is daily maximum doses recommended to give
newborns (Kedrick, 2018). The maximum dose for a baby between birth to one month of age is 5
milliliters (Kedrick, 2018). So the nurse must keep track of this to monitor the baby’s intake of
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sucrose to ensure the dose does not overstep the maximum range. This is a safe therapeutic
measure to take when NAS patients become inconsolable and prevents an increase of Finnegan
scores which will avoid an increase of medication dose.
The third and final therapeutic therapy option that hospitals can put in place to help
newborns go through withdrawal is starting a volunteer program for people to “cuddle” the
babies. It is unrealistic to think that NICU nurses can sit and hold their NAS patients all day, but
in reality that is what they truly need to be calm and decrease their symptoms (Kraynek,
Patterson & Westbrook, 2012). A great way to combat this is implementing a program for people
to offer their time to hold the babies for periods throughout the day. The volunteers must go
through background checks, screening, and education before coming to the unit. They also will
be checked on frequently by the nurse and will be able to get in touch with him/her if an issue
arises. The safety measures are a top priority for the staff so, per unit protocol, the baby is always
monitored via EKG, pulse oximetry, and identification location bands. The cuddlers do not only
benefit the time management of the nursing staff, they have also proven to help the baby’s
withdrawal symptoms (Kraynek, Patterson & Westbrook, 2012). Western Pennsylvania Hospital
began a study to see if their cuddler program actually helped the patients. A group of NAS
patients with cuddlers was compared to a group who were not in the program. Their findings
showed that the babies who were cuddled had a decreased length of stay by 3.8 days on average
(Kraynek, Patterson & Westbrook, 2012). This confirmed that the program was viable and truly
did have major positive effects on their NAS population. And in two years this hospital’s
volunteers had completed 2,855 hours of cuddling NAS babies (Kraynek, Patterson &
Westbrook, 2012). This program is low cost because the people are volunteering 100% of their
time and energy to the babies; the only cost is education. Many of the volunteers truly enjoy the
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programs because of a personal connection they have with the population or unit in general.
David Deutchman is known as the “ICU Grandpa” at Children’s Healthcare of Atlanta because
he has been giving his time to the unit for 12 years and because of the special baby touch he
seems to have on all the fussy patients (Vieira, 2017). The cuddler program has had such a great
impact that Huggies diapers has started an initiative called “No Baby Unhugged” which is trying
to create these programs at hospitals in Canada currently (No Baby Unhugged, 2020). Their tag
line for this program says “Huggies Brand has always believed in the power of hugs. And we
want to help ensure all babies get the hugs they need, even when moms and dads can’t be there
to give them.” (No Baby Unhugged, 2020). This is an inexpensive way that NICUs across the
country are able to decrease the withdrawal symptoms without medications.
Rooming-In
The most important non-pharmacological therapy option that seems to have the most
benefits for these infants is rooming-in with their mothers. Most infants will be transported to the
NICU once signs and symptoms of withdrawal begin so that they can be watched more closely
and administered medications on a regular basis. This instantly separates the mother-infant-dyad
which results in harmful outcomes for the baby and mother-baby bond. “Such a prolonged
admission is disruptive to the infant’s family and is likely to interfere with mother and infant
bonding.” (Saiki et al, 2009). Hospital systems have recognized this issue and came up with a
possible way to combat the problem. A solution is for the mother and baby to be kept together
during this withdrawal period so that bonding and overall wellbeing of the relationship can
continue. The benefits of rooming-in are higher incidences of breastfeeding, lower medication
dosages, decreased length of stay, lower Finnegan scores, and possible lower overall associated
costs (Mangat, Schmolzer & Kraft, 2019). Many studies have been done on the effectiveness of
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rooming in on breastfeeding rates. One study found that 63% of infants rooming in with their
opioid-dependent mothers were breastfeeding in the hospital, while only 10% of infants left in
the NICU to withdrawal were being breastfed (Mangat, Schmolzer & Kraft, 2019). Since the
baby is in close proximity to the mother, breastfeeding is logistically a much easier task than
traveling from postpartum or home every two hours; it was previously noted the great benefits
that breastfeeding can have on NAS, so any encouragement to increase the rate is a positive
thing. Rooming-in has also shown to decrease the length of stay for this population. A research
study completed in 2017 compared 86 mother-infant pairs and found that the overall length of
stay was reduced by nine days for babies allowed to room-in with their mothers (Kondili &
Duryea, 2019). Another study showed that rooming-in decreased the length of stay from 41.5
days to 33 days (Boucher, 2017). Lowering the time of hospital stay is mostly due to the lower
medication dosages that are prescribed during the hospital stay because of their mother’s impact.
Research has shown that NAS patients rooming-in required 20-60% less medication treatment
than for babies who stayed in the ICU (Wachman, Schiff & Silverstein, 2018). Their overall time
of taking these medications is also reduced by 8 days on average (Mangat, Schmolzer & Kraft,
2019). While more studies need to be completed, the findings thus far indicate a positive
outcome for rooming-in. The majority of NAS babies are transported to the NICU for worthy
reasons – vital sign changes, medication dosing, closer monitoring, and controlling the
symptoms. While these are all valid motives for transferring units, the benefits of leaving them
with moms need to be considered.
While allowing the babies to stay with mom may be best, there are many logistical issues
that arise when creating a program to allow mothers to stay with their newborns. To begin with
the medical staff needs to remember that the mother is the beginning reason that the baby is
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going through NAS, so the infant’s safety needs to be priority before allowing them to stay in a
room alone with mom (Mangat, Schmolzer & Kraft, 2019). There may be unsafe situations that
prevent the baby from being kept with mom and in that situation it is much better for baby to be
placed in the NICU’s safe environment (Mangat, Schmolzer & Kraft, 2019). NICUs that are
creating rooming-in options require the mother to be in some sort of program to end their
addiction that includes urine screening, opioid replacement medications, counseling, and home
visits (Mangat, Schmolzer & Kraft, 2019). The mother has to prove to the hospital, her addiction
program, and child protective services that she is on a path of breaking her addiction so the baby
will have a safe home environment after discharge (Mangat, Schmolzer & Kraft, 2019).
Addiction is a difficult battle to overcome, so this may not be an option for some mothers who
are unwilling to treat their problem. The staffing strategy creates another issue with rooming-in
because the infant truly needs an ICU provider and nurse completing frequent checks and
assessments instead of a postpartum or pediatric nurse whose education and daily assignments
are different. This is much more difficult to do when the baby is not feet away from the nurse’s
desk, but rather the nurse has to travel some distance to do her checks. Staffing arrangements
must be reconsidered when rooming-in is offered. Another issue that arises when the hospital is
trying to create an opportunity for rooming-in is finding the space to accommodate the mom and
infant. Some hospitals have created a whole new unit/section for rooming-in, but that has large
costs associated with it (Ryan et al, 2017). Others have given them open rooms in the postpartum
or pediatrics units as that is available. But census changes often, so those rooms may be needed
by critical patients. The ‘where to place them’ question is the largest issue surrounding this
opportunity. If a rooming location can be negotiated, rooming-in actually has proven to decrease
the cost of NAS infant’s hospital stay.
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A comprehensive study was completed for the Society for Maternal-Fetal Medicine
concerning the overwhelming costs of NAS admissions. The investigators looked at newborns
with NAS across the country to gather data on the costs regarding length of stay if rooming-in or
staying in the ICU. They found that the average cost of stay for an NAS infant who was
administered pharmacological therapy in the NICU was $22,432 (Avram, 2019). Average cost of
stay for neonates rooming in with mom and administered medications dropped significantly, to
$9,469 (Avram, 2019). This large difference is caused by how much less medication has to be
administered, less staff time, more breastfeeding rather than using formula, and less medical
intervention. This study concluded that rooming-in decreased costs in 94.2% of their patients
(Avram, 2019). This cost comes from hospitals that already have placement for the mother-infant
dyad and does not include the hospital’s costs for either building a new space or taking rooms
away from a nearby unit. So, while ultimately it decreases costs, there must first be major
financial dedication to organizing a rooming-in program. This is the largest issue for hospitals
and why the majority of them have not opened a rooming-in option for the NAS mothers.
Hospital system must look to the research to see the great benefits that rooming in can offer their
NAS patients before declining to invest.
Discussion
The benefits of implementing non-pharmacological therapy protocols for patients
experiencing NAS is clear. The actual choice and implementation stages of this process can look
very different from hospital to hospital; but the traditional methods of solely treating these
patients with medications alone should no longer be the case. Budgets are different depending on
the area and size of the hospital system, but some of these interventions like providing low
stimulus, encouraging breastfeeding, positioning, and family education have little to no cost

20

associated with them. NICUs need to begin educating their staff about these ways to decrease
withdrawal without medications solely. Steps can be made in the right direction for these patients
in order to decrease their symptoms and length of stay in addition to or without the use of
medications.
Some of the limitations surrounding this thesis would be that these treatment options
have not yet be accepted widely, so the research surrounding the information is limited. As the
years go on and hospitals recognize the benefits of these therapies more information will be
published. Another limitation encountered during this project is the lack of personal information
that can be publically distributed due to HIPPA regulations for patient privacy and
confidentiality. This made it difficult to find personal stories or information from patients or
parents that could further my different points.
Conclusion
NICUs across America are seeing an ever growing number of infants presenting in
withdrawal from their mother taking addictive substances during pregnancy. Neonatal
Abstinence Syndrome has reached a level where hospitals are having to come up with new ways
to combat the issue and care for their patients. The traditional way of administering opioids once
withdrawal symptoms appear should no longer be the first line treatment. While there are
situations where medication must be given to treat the patient, non-pharmacological therapies
should be considered first in the majority of cases. Nodding to the fact that the healthcare system
in America is struggling for dollars, there are many ways to treat the infant without going broke.
Controlling their environment to be low stimuli really helps these hypersensitive infants
overcome their withdrawal period. This can be as simple as turning the light off over their crib,
completing cluster care as a medical professional, and placing their bassinette in the quietest area
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of the unit. The units can even create low-stimuli pods to promote their healing as well. Other
simple ways to control their environment are positioning them in the prone positon, placing them
on a waterbed instead of traditional mattress, and swaddling them. Education about breastfeeding
prenatally and postpartum can do wonders for these babies entering withdrawal. Breastfeeding
has been proven to decrease medication administration doses and lower length of stay. If
breastfeeding is not an option, then the type of formula should be tailored to promote growth and
healing in these patients. Also, holding them upright after feeds, giving them a slow-flow nipple,
and doing small frequent feeds will help decrease their GI upset. Some therapeutic options to
help treat NAS withdrawal is acupuncture, giving oral sucrose, and creating a cuddler volunteer
program. All of these things are low cost and have proven to be very effective. Finally, a more
expensive but very effective method to non-pharmacologically combat NAS is allowing the
mothers to room-in with their babies after birth. While it is associated with higher costs initially
and can create some administrative issues, the research shows that it greatly benefits these
patients by decreasing stay, decreasing medication administration, promoting breastfeeding, and
lowering final costs for the patient. These are successful ways hospitals can deal with the ever
growing issue of increased NAS infants being admitted without using medication.
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